Antibody to Omalizumab ELISA

Enzyme immunoassay for the semi-quantitative determination of free antibodies to Omalizumab (Xolair®) in serum and plasma.

The solid phase (MTP) is coated by the drug Omalizumab. Due to the assay design this test only measures the free antibodies which are not bound to Omalizumab. Results are expressed in AU (arbitrary units).

Reference: IG-BB111

Barcode: 8699316552451

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

ig-bb111

Related Documents


Quality Control Certificates

Xolair® is a trademark of Genentech Inc.

The Kit at a glance:

ig-bb111

Required Volume (µL) 10
Incubation Time (min) 135
Sample Serum or Plasma
Package Size 96 Tests
Results in Arbitrary Units (AU/mL)
Cut-Off 3 AU/mL
Shelf Life (years) 2